L. Gras

Estimation of the Incidence of Late Bladder and Rectum Complications After High-Dose (70–78 Gy) Conformal Radiotherapy for Prostate Cancer, Using Dose–Volume Histograms

L. Boersma, M VANDENBRINK, A Bruce et al. · International Journal of Radiation Oncology*Biology*Physics · 1998 · 396 citations

Medicine, Radiation Oncology, Urology +16

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 232 citations

Medicine, Oncology, Chemotherapy +14

Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck

Patrick Schöffski, G. Catimel, A.S.T. Planting et al. · Annals of Oncology · 1999 · 104 citations · Full text

Medicine, Oncology, Chemotherapy +12

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours

Christelle Lévy, Djelila Allouache, Joëlle Lacroix et al. · Annals of Oncology · 2014 · 59 citations · Full text

Medicine, Neurosurgery, Oncology +14

Complementary and alternative medicine use in glioma patients in France

Émilie Le Rhun, Patrick Devos, Veronique Bourg et al. · Journal of Neuro-Oncology · 2019 · 13 citations

Medicine, Neurology, Oncology +11